TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 139 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $2,518,000 | -14.8% | 657,496 | -4.3% | 0.08% | -24.1% |
Q2 2016 | $2,954,000 | +12.3% | 686,921 | +20.9% | 0.11% | +12.5% |
Q1 2016 | $2,630,000 | -54.2% | 568,001 | -0.9% | 0.10% | -51.5% |
Q4 2015 | $5,748,000 | -9.4% | 573,101 | -32.6% | 0.20% | +1.0% |
Q3 2015 | $6,345,000 | -81.0% | 850,601 | +20.5% | 0.20% | -79.3% |
Q2 2015 | $33,474,000 | +26.8% | 705,601 | -2.1% | 0.95% | +25.4% |
Q1 2015 | $26,409,000 | +7.5% | 720,781 | +16.5% | 0.76% | +5.4% |
Q4 2014 | $24,575,000 | +299.5% | 618,860 | +100.7% | 0.72% | +277.4% |
Q3 2014 | $6,152,000 | – | 308,360 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 317,900 | $11,647,000 | 4.28% |
Opaleye Management Inc. | 175,000 | $6,412,000 | 2.98% |
Graticule Asia Macro Advisors LLC | 413,200 | $15,139,000 | 2.02% |
BB BIOTECH AG | 1,477,114 | $54,121,000 | 1.61% |
Iguana Healthcare Management, LLC | 75,000 | $2,748,000 | 1.16% |
Granite Point Capital Management, L.P. | 79,250 | $2,904,000 | 1.06% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 458,202 | $16,788,000 | 0.89% |
Ghost Tree Capital, LLC | 130,000 | $4,764,000 | 0.86% |
SECTORAL ASSET MANAGEMENT INC | 605,393 | $22,182,000 | 0.84% |
HealthCor Management, L.P. | 467,200 | $17,118,000 | 0.82% |